B Cell Response to Vaccination.
Immunol Invest
; 50(7): 780-801, 2021 Oct.
Article
in English
| MEDLINE | ID: covidwho-1155729
ABSTRACT
As one of the most important weapons against infectious diseases, vaccines have saved countless lives since their first use in the late eighteenth century. Antibodies produced by effector B cells upon vaccination play a critical role in mediating protection. The past several decades of research have led to a revolution in our understanding of B cell response to vaccination. Vaccines against SARS-CoV-2 coronavirus were developed at an unprecedented speed to power our global fight against COVID-19 pandemic. Nevertheless, we still face many challenges in the development of vaccines against many other deadly viruses, such as human immunodeficiency virus (HIV) and influenza virus. In this review, we summarize the latest findings on B cell response to vaccination and pathogen infection. We also discuss the current challenges in the field and the potential strategies targeting B cell response to improve vaccine efficacy.Key abbreviations box BCR B cell receptor; bNAb broadly neutralizing antibody; DC dendritic cells; DZ dark zone; EF response extrafollicular response; FDC follicular dendritic cell; GC germinal center; HIV human immunodeficiency virus; IC immune complex; LLPC long-lived plasma cell; LZ light zone; MBC memory B cell; SLPB short-lived plasmablast; TFH T follicular helper cells; TLR Toll-like receptor.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
B-Lymphocytes
/
Pandemics
/
COVID-19 Vaccines
/
COVID-19
Topics:
Vaccines
Limits:
Animals
/
Humans
Language:
English
Journal:
Immunol Invest
Journal subject:
Allergy and Immunology
Year:
2021
Document Type:
Article
Affiliation country:
08820139.2021.1903033
Similar
MEDLINE
...
LILACS
LIS